title: Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.
authors.affiliation: Centre hospitalier, BP 29, 68250, Rouffach, France. macrocq@forenap.asso.fr
authors.forename: M A
authors.initials: MA
authors.lastname: Crocq
authors.forename: Ph
authors.initials: P
authors.lastname: Leclercq
authors.forename: M S
authors.initials: MS
authors.lastname: Guillon
authors.forename: P E
authors.initials: PE
authors.lastname: Bailey
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D012008:Recurrence; D018967:Risperidone / Q000008:administration & dosage / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D018967:Risperidone; D000077152:Olanzapine